Trials / Unknown
UnknownNCT05965661
A New 3D Virtual Reality-based Upper Limb Training to Improve Dexterity in Parkinson's Disease
A New 3D Virtual Reality-based Upper Limb Training to Improve Dexterity in Parkinson's Disease: a Randomized Pilot Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Luzerner Kantonsspital · Academic / Other
- Sex
- All
- Age
- 40 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
We investigate the impact of a 4-week virtual reality-based upper limb training in Parkinson's disease. The benefits on dexterity of this training program will be evaluated. For these purposes, a randomised, two arm, single assessor blind, parallel design with a monocentric, study setup will be performed.
Detailed description
Patients with Parkinson's disease (PD) suffer from significantly decreased coordination and have difficulties with precise hand/finger movements during the performance of both basic activities of daily living (ADL), such as dressing, grooming as well as higher ADL, such as cooking, shopping and regular medication intake. These difficulties further add to the burden of the disease, leading to reduced quality of life (QoL). A relatively new, but rapidly growing aspect of training in PD neurorehabilitation offers virtual reality (VR). We explore the effects of a VR-based upper limb hand training compared to a VR control training, which is less specific for dexterity. Moreover, we examine the effetcs of the trainings on upper limb related ADL, and therefore the impact on QoL in patients with PD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | virtual reality upper limb hand training | The PD patients randomized in the experimental group will receive virtual reality upper limb hand training. |
| OTHER | virtual reality control training | The PD patients randomized in the control group will receive virtual reality control training. |
Timeline
- Start date
- 2023-07-19
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2023-07-28
- Last updated
- 2023-07-28
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT05965661. Inclusion in this directory is not an endorsement.